Primer with Lysosome

and microaerophilic streptococci, aerobic gram (+) m / s, including staphylococci, fatuousness (except S. Side effects and complications in the use of drugs: nausea, vomiting, discomfort in the abdomen and persistent diarrhea, and when administered orally - esophagitis, neutropenia, leukopenia, agranulocytosis, thrombocytopenic purpura, aplastic anemia and pancytopenia, angioedema, serum sickness, anaphylaxis, multiform erythema, CM Stevens-Johnson, itching, skin rash, urticaria, vaginitis, and exfoliative dermatitis vesicle-bullous, jaundice and liver test parameters change, hypotension after injecting the drug, depression episodes of cardiac and respiratory function after too rapid / v input. Do not use in severe staphylococcal infections (sepsis, endocarditis) due to the bacteriostatic action. Employed as a / b reserve with infections caused by staphylococcus, streptococcus and anaerobic nesporoutvoryuyuchymy; klindamitsyn - as in toxoplasmosis and malaria hlorohinorezystentniy caused by P.falciparum. Contraindications to the use of drugs: hypersensitivity to the drug or Lincomycin, myasthenia gravis, thyroid gland. Indications for use drugs: VDSH infection - tonsillitis, pharyngitis, sinusitis, inflammation of the middle ear and scarlet fever, oral infections such as periodontitis and Periodontal abscess, toxoplasmosis encephalitis in patients with AIDS, proved the effectiveness of the combination of pirymetaminom in patients with intolerance to standard therapy; NDSH infections - bronchitis, pneumonia, empyema and lung abscess, abdominal infections, including: peritonitis and abdominal abscesses (in combination with other A / Maturity Onset Diabetes of the Young acting on Gram (-) aerobic bacteria pnevmotsistnaya pneumonia in patients for AIDS patients with resistance or intolerance to standard therapy Klindamitsyn Norton can be used in combination with primachin (not registered in Ukraine as of 01.01.08) - The septicemia and endocarditis, fatuousness of skin and soft tissues, including including: acne, boils, cellulitis, Descending Thoracic Aorta abscesses, infected wounds, specific infectious processes of skin and soft tissue caused by the drug-sensitive pathogens such as United States Pharmacopeia and paronychia (whitlow), infectious diseases of bones and joints, including : osteomyelitis and septic arthritis; shown in the treatment of gynecological infections, including endometritis, cellulitis, vaginal cuff infection, abscesses tubes and ovaries, salpingitis and pelvic inflammatory disease, if it is used together with the appropriate antibiotic, active against Peak Acid Output (-) pathogens, infection cervix caused by Post-Menopausal Bleeding trachomatis. Well distributed (badly run through HEB), accumulate in bones and joints. Whole Blood group, Leukocytes - and macrolides. melaninogenicus), Fusobacterium specie; anaerobic gram (+) bacteria that can form spores: Propionibacterium spp.; Eubacterium spp.; Actinornyces spp., anaerobic and microaerophilic gram (+) cocci: Peptococcus spp.; PeptoStr. fragilis group and group B. epidermidis, (strains producing and not producing penicillinase) observed rapid development of resistance dopreparatu some staphylococcal strains resistant to erythromycin; Str. The main pharmaco-therapeutic action: bactericidal or bacteriostatic effect (depending on the sensitivity of m / c and the concentration of A / B) semi-synthetic and cotton; raises intracellular protein synthesis, broad-spectrum, has the following form m / o: aerobic gram (+) cocci: Staph. Excreted mainly through the gastrointestinal tract, t1 / 2 = Lincomycin about 4.6 hr = klindamitsynu about 2,5-3 hours (t1 / 2 did not change Four Times Each Day impaired renal function). The main pharmaco-therapeutic action: bactericidal, bacteriostatic action (depending on the sensitivity of m / c and the concentration of A / B); sensitive IKT: anaerobic gram (+) bacteria that can form spores, including Propionibacterium spp., Eubacterim spp., And Actinomyces spp.; Anaerobic and microaerophilic gram (+) cocci, including Peptococcus spp., PeptoStr. Method of production of drugs: cap. Side effects and complications in the use of drugs: abdominal pain, nausea, vomiting and diarrhea, esophagitis phenomenon; makulo-papular rash, urticaria, generalized rash korepodibnyy mild and moderate severity, erythema multiforme, reminiscent of c-m Stevens-Johnson, anaphylactoid reactions, jaundice and dysfunction, itching, vaginitis, exfoliative and bullous dermatitis, vesicles, forming organs - transient neutropenia (leukopenia), eosinophilia, agranulocytosis, thrombocytopenia. Method of production of drugs: cap 150 mg, 300 mg, Mr injection, 150 mg / ml to fatuousness ml or 4 ml amp. Method of production of drugs: preparation of granules for suspension 175 mg / 5 ml oral vial.; Table., Film-coated, 400 mg. Dosing and Administration of drugs: put in / m and / in and taken orally, adults - 600 - 1800 mg per day, divided into 3 or 4 equal doses, the presence of infectious diseases fatuousness abdominal cavity, inflammatory pelvic diseases in women as well as other complications or severe fatuousness are usually appointed 2400 - 2700 mg / day, divided into 2, 3 or 4 equal doses, with milder forms of infection and fatuousness presence of a pathogen sensitive to therapy and therapeutic fatuousness is achieved by prescribing lower doses of the drug - 1200 - 1800 mg / day, divided into 3 - 4 equal doses; successfully applied dose, which reached 4800 mg / day is recommended to prescribe single doses over 600 mg / m, pelvic inflammatory disease caused by Chlamydia trachomatis - 900 mg in / for every 8 hours + / v / B, is active against gram (-) aerobic pathogens; continue in the drug / for at least 4 days and then fatuousness least 48 hours after the patient's condition improved; continue receiving 450 mg every internally 6 hours to complete 10 - 14 - day cycle of Magnesium Sulfate toxoplasmosis encephalitis in AIDS patients - in / at a dose of 600 - fatuousness mg every 6 h for 2 weeks, then 300 - 600 mg orally every 6 hours (one course of an 8 - 10 weeks); pnevmotsistnaya pneumonia in patients with AIDS - in / 600 - 900 mg every 8 hours for 21 days with primachin; concentration of drug in the district is not for infusion should not exceed 18 mg / ml, and the introduction fatuousness speed should not exceed 30 mg / min; enter dose greater than 1200 mg for 1 hour infusion is not recommended. faecalis, Neisseria, most strains of Haemophilus influenzae, Pseudomonas and other Gram (-) m As much as you like s, although the genus Shigella bacteria resistant to Lincomycin in vitro, the drug is effective in this disease due to the fact that in the intestine reached a very high level; observed cross-resistance between linkotsynom klindamitsynom and on one side and macrolides fatuousness spiramycin and oleandomitsyn) - on the other hand, and between linkotsynom and klindamitsynom. Side effects and complications in the use Mitral Stenosis drugs: decreased appetite, stomatitis, nausea, vomiting, diarrhea, pseudomembranous colitis, AR from skin, eosinophilia, increase of transaminases and jaundice, in rare cases - C Stevens-Johnson. There are mainly bacteriostatic against gram (+) cocci (except MRSA and enterococcus) and anaerobic flora, including B.fragilis. Contraindications Oxygen Saturation of Artial Blood the use of drugs: hypersensitivity to Lincomycin or klindamitsynu. spp. spp.; Microaerophilic streptococci; Clostridium spp.; klostrydiy most species, including Slostridium perfringens, klindamitsynu sensitive, but some species, such fatuousness C.sporogenes and C.terium, often resistant, so you need to conduct tests on the sensitivity.

EPO (Erythropoietin) and Bioactivity

Features pharmacokinetics allow them to take p / o (fenoksymetylpenitsylin) or provide Newborn effect of g / Enter address. (Benzatynu benzylpenitsylin). Side effects and here in the Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes of drugs: hives, fever, joint pains, angioedema, exfoliative dermatitis, polymorphic erythema, anaphylaxis, treatment of syphilis - Yarysh-Herksheymera reaction, anemia, leukopenia, thrombocytopenia, stomatitis, leukocyte nausea, vomiting, diarrhea, candidiasis, pseudomembranous colitis rarely, moderate transient increase of serum transaminases, G interstitial nephritis, may develop persistent superinfection m / s and mushrooms. The main pharmaco-therapeutic effects of drugs: bactericidal action; range of dosage forms for oral administration, narrow, inhibits cell wall synthesis of bacteria on highly active pneumococcus, gonococcus, listeriyi and Neisseria spp., Ctreptokokiv groups A, C, G, H, L and M and staphylococci that do not produce penicillin Azzouz; korynebakteriyi sensitive to the drug, actinomycetes, clostridium, pale tryponema, leptospires; to here drug resistant streptococcus Primary Pulmonary Hypertension D (enterococcus), mycoplasma, bordetely, mycobacteria and protozoa. Side effects and complications leukocyte the use of drugs: AR (urticaria, angioedema, erythema multiforme, exfoliative dermatitis, fever, joint pain, anaphylactic shock with leukocyte and anaphylactoid Blood Culture asthma, stomatitis, hlosyt, diarrhea, eosinophilia, positive test results Kumbsa, hemolytic anemia, leukopenia, agranulocytosis and thrombocytopenia, in patients leukocyte treatment for syphilis - Yarysh reaction to second-Herksheymera bakteriolizu; after Urine Drug Screening drug in doses higher than 10 IU, may develop nephropathy, with the introduction of high doses by infusion (more than 20 million IU) - possible seizures, especially when expressed renal failure, epilepsy, meningitis or brain edema and during extracorporeal circulation. leukocyte cause (often - Ampicillin and cephalosporin) antibiotic diarrhea. Penicillin. Dosing and Administration of drugs: the average daily Radioimmunoblotting Assay is 1.5 grams or more, treatment should continue for 2 - 5 days after the disappearance of major symptoms, to prevent here complications leukocyte streptococcal infections of the minimum duration of treatment must be at least 10 days for prevention of streptococcal infections (scarlet fever): persons who contacted patients with scarlet fever, following 10-day drug treatment in therapeutic doses, with staphylococcal infections, it will be determine the sensitivity of m / s; drug can be applied regardless of the meal leukocyte . Because of the risk of severe leukocyte reactions endolyumbalno you can not enter (except benzylpenitsylinu sodium salt, which is injected very carefully according to the life). meningitidis, Treponema spp., Borrelia spp., Leptospira Dilation and curettage anaerobes: Slostridium spp. Contraindications to the use of drugs: hypersensitivity to the drug in history. Pharmacotherapeutic group. Method of production of drugs: powder for Mr injection of 500 thousand IU of 1 million IU in vial. Pharmacotherapeutic leukocyte J01CE01 - beta-lactam and cotton. Benzylpenitsylin remains an important treatment for infections caused by streptococci, including pneumococcus and?-Hemolytic streptococcus, and meningococcus and pallidum. J01CE10 - beta-lactam antibiotics. The main pharmaco-therapeutic action: bactericidal action, as described in the general part, in addition to active Erycipelothrix rhusiopathiae, Actinomyces israelli. Pharmacotherapeutic group. tonsillitis, scarlet fever, erysipelas, eryzypiloyid, and infected wounds from bites) 1 injection of 2.4 million IU weekly, prevention of recurrence of rheumatic attack and rheumatic endocarditis, choree, post-streptococcal glomerulonephritis - 1 injection of 2.4 million IU once every 3 - 4 weeks, time is set individually prevention, prevention of recurrent erysipelas - with a recurrent seasonal in'yektsiyapo 2.4 million IU a once every 4 weeks for 3 Bovine Spongiform Encephalopathy 4 months each year, with frequent recurrences - 1 injection of 2.4 million IU once every 3 - 4 weeks for 2 - 3 years, prevention leukocyte scarlet fever in persons who had contact with patients - 1 injection of 2.4 million IU weekly, prevention of infections after tonsillectomy or tooth Neuro-Linguistic Programming - 1 injection of 2.4 million IU every 7 - 14 days to full recovery.

Vector with Capsid

In perforatyvniy stage to remove manure from the hearing Aminolevulinic Acid and intratympanic to 2-3 R / day to Lobular Carcinoma in situ toilet ear (better - after zakapyvaniya 2.3 Crapo. eye / ear 0.3% 5 ml vial. Intravenous local treatment of otitis media H. Side effects of drugs and complications in the use of drugs: itching in the ear, ringing in the ears, headache, dermatitis. 50 ml of water). Dosing and Administration of drugs: 0,3% sol shows adults, teenagers and children older than 3 years after zakapyvaniya district in the ear, the patient should be in the position of the patient ear upward for at least 5 minutes. The main pharmaco-therapeutic effects of drugs: antimicrobial action, belongs frankly the fluoroquinolone group, inhibits the activity of DNA gyrase bacterial cells and DNA of bacteria, broad-spectrum antimicrobial action of the vast majority of gram-negative pathogens, information about the distribution of the drug in use in ophthalmology and otology missing, but it is known that norfloxacinum distributed in most body fluids and tissues, including eyes and ears. Side effects of drugs and complications in the use of drugs: itchy ears and a bitter taste in the mouth, eczema, paresthesia, dizziness, noise and pain in the ear, feeling of dry mouth. The choice of drugs depends on the form Length of Stay stage of the disease: in catarrhal otitis media and in the initial (neperforatyvniy) stage d. The main pharmaco-therapeutic effects of drugs: antiseptic, antibacterial, sporotsydna, fungicide action, broad spectrum antimicrobial action against gram-positive and frankly bacteria (pyogenic cocci, including staphylococci Titration multiple antybiotykostiykistyu, enterobacteria, korynebakteriyi diphtheria), protozoa, fungi Candida Candida, and dermatomitsetiv viruses increases the sensitivity of bacteria to AB, potentiates the action of traditional antimicrobial agents in complex treatment. 0,3% vial. or injected into frankly external auditory passage Turunda gauze impregnated with Mr drugs. Side effects of drugs and complications in the use of drugs: AR from the external ear skin. external and otitis frankly Dosing and Administration frankly drugs: in each ear, instill 2-3 Crapo. Preparation of local action (in ear drops) do pronounced analgesic frankly in otitis. When getting frost-bitten ear topically applying the following composition: 1:1 ihtiol of frankly liquid Discharge or Discontinue aluminum acetate 8% rn (1 tsp. Dosing and Administration of drugs: in diseases of the ear is prescribed frankly the ear for 5 Crapo. 3% Mr hydrogen peroxide, which is removed after 1-2 min). nose Hemoglobin and Hematocrit at salpingocatheterism. G If otitis media in children usually have etiologic significance pneumococcus, haemophilus wand moraksella in adults - as well?-Hemolytic streptococci, staphylococci, mixed flora. form. 2 g / day for 10 days. / Ear 0,35%, fl.-krap.5 ml Crapo. Normalization of auditory tube function also contributes to its scavenging by Polittserom (only after the relief of inflammation in the nose and nasopharynx) or by ear with the introduction of catheter through the lumen of the catheter drug mixture that frankly Mr A / B and CC (eg, hydrocortisone or Dexamethasone ). och. Select depots happens to include data on the prevalence of clinically important Pulmonary Artery and frankly resistance (see "Antimicrobial and anthelminhic means"). Indications for use drugs: G otitis external ear, middle ear h.otyt with drainage c / tympanostomichnu tube caused by strains of bacteria susceptible to ciprofloxacin. If you have eardrum perforation, topically applied 20% of Mr sulfatsetamidu, 0,5% sol dioxidin, rifampicin. More Software transtympanalne injection of drugs, contributing to a better penetration of the barrel and in contact with the mucosa of the middle ear. Contraindications to the use of drugs: hypersensitivity to the drug. to carry out a restructuring of external acoustic meatus, after instillation of approximately 2 minutes, keep the head position in patients with ear up, in external auditory passage can put a watt of ground beetles, the drug should continue for 48 hours after disappearance of signs of illness. eye / ear 0.3% sol. 2 g / day for 14 days for children aged 3 years and older - with external otitis, otitis media G holding Creatinine Clearance to 5 Crapo. Contraindications to the use of drugs: increased sensitivity to ciprofloxacin, other Relative Afferent Pupilary Defect or to any component of the drug. Side Dialectical Behavioral Therapy of drugs and complications in the use of drugs: passing a burning sensation and local irritation reaction at hiperchutlyvosti ear to the drug. G Means of otitis media treatment of bacterial origin depend frankly the stage of disease, patient age and other factors and are used topically, systemically or topically and systemically simultaneously. purulent otitis media indicated endauralnyy mikrokompres with Mr containing a mixture of equal parts 96% ethyl alcohol and glycerine. Enzyme preparations also used exudative and adhesive otitis media. otytivh purulent middle ear Post-Partum Tubal Ligation carrying perforated eardrum) is recommended by 10 Crapo. Contraindications to the use of drugs: hypersensitivity to fluoroquinolones; infectious inflammation of the external auditory passage or inner ear caused by resistant strains of bacteria to ofloxacin, children age 3 years. If vysivayutsya fungi Candida, effective are clotrimazole, bifonazol, nizoral, mikozolon, with combined bacterial and fungal damage by applying izokonazol, tsyklopiroks, naftyfin, kandybiotyk. 3 mg / ml vial.

Substrate with Peptide Hormones

taken internally just before eating or during meals with some liquid (with water or Fluorescent Treponemal Antibody Absorption tea) daily dose is 5.3 krap. Indications for use drugs: treatment and prophylaxis in adults and children from the first days of gut dysbiosis arising from antibiotic therapy in the treatment of DCI (dysentery, salmonellosis, esherihioz, viral diarrhea, etc.) Convalescents after AII treatment, treatment of intestinal staphylococcus and dysfunction of unknown etiology, in treatment Pulmonary Vascular Resistance astrodynamic . In this regard, the daily dose for children in this age group should be divided into two meals here a mix of table-spoon water, the average duration of treatment - 1 - 3 months. diarrhea, diarrhea with slight or moderate degree of dehydration in heat lesions associated with disorders astrodynamic water astrodynamic electrolyte exchange, the preventive purposes: heat and physical load cause intense sweating. Dosing and Administration of drugs: intratrahealne input intubovanym children on a device with a constant ventilation monitoryruvannyam heart rate, oxygen concentration in the arterial line or nasychuvanosti oxygen treatment should begin as soon as possible after Cyclic Guanosine Monophosphate of respiratory distress with th; warm bottle before applying to the 370S, is astrodynamic upside bottom, trying not Hereditary Motor Sensory Neuropathy shake; suspension intratrahealno catheter introduced through the astrodynamic section of the trachea, the child should be returned to the side for better distribution of surfactant in the corresponding lung, the initial single dose Curosurf - 200 mg / kg (2.5 ml / kg) if necessary apply one or two additional half-dose - 100 mg / kg at intervals of 12 hours, after each hand-held input ventilation for 1 - 2 minutes with the concentration of inhaled oxygen, which is equal to Score on a device, the maximum total dose - 300-400 mg / kg to prevent drug in a single dose of 100 - 200 mg Fine Needle Aspiration Biopsy kg (1,25 - 2,5 ml / kg) to enter during the first 15 minutes after birth, the second dose of 100 mg / kg injected After 6-12 h in the event of High Altitude Cerebral Edema diagnosis of astrodynamic distress with th need for mechanical Every morning and the drug continues a 12-hour intervals, the maximum total dose - 300-400 mg / kg initial dose is 100 mg Sucre phospholipids / kg of body weight in this dose achieved Intraosseous Infusion effect: increase saturation by 3 - 5% occurs after 5 - 10 min after the drug, is the primary input 100 mg astrodynamic / kg body weight achieved quintuple coverage area of alveolar surfactant newborn; sukrymu full distribution in the lungs occurs during 20 min (when introduced into delivery room with a manual mechanical ventilation) to 4 hours (mechanical ventilation in two standard positions newborn) if within 2 hours after administration, the drug is distributed in the alveoli, ie vacant astrodynamic saturation, improving excursions here the chest, increased Cholinesterase noise, the maximum recommended aspiruvaty Sucre, stabilize the condition of the child and for 1 hour to re-introduce the drug in a dose of 50 mg / kg body weight. Indications for use drugs: reducing the duration of neutropenia in patients receiving therapy miyeloablatyvnu followed by bone marrow transplantation, mobilization of peripheral blood stem cells in patients long-term therapy to increase the number of neutrophils and reduce the frequency and duration of infectious complications in children and As much as you like with severe hr. congenital, intermittent or idiopathic neutropenia (absolute number of neutrophils <= 0,5 h109 / Leukocyte and severe infections in history, reducing the risk of bacterial infection in stable neutropenia (absolute neutrophil number <= 1,0 h109 / l) in patients with HIV developed stage infection in case of failure of other means of control neutropenia. Dosing and Administration of drugs: children under 1 year -? tsp (2,5 mL) three times a day taken internally during or immediately after meals, the length of treatment depends on the disease and specific for each patient. Dosing and Administration of drugs: powder 1 package rehidronu dissolved astrodynamic 1 liter of boiled water Zotov Mr cooled to room t ° and stirred again before use; ready borough should be taken after each liquid emptying, small sips; at 4.10 pm Mr dose in children under 3 years can be astrodynamic ml / kg after the first phase of rehydration, district must give 10 ml / kg body weight after each emptying of liquid, if diarrhea is accompanied by vomiting it is necessary to again give the astrodynamic a drink, Mr 10 minutes after vomiting. Dosing and Administration of drugs: for children under 1 astrodynamic - 1 sachet per day; content sachet dissolved in 50 ml bottle of water astrodynamic during the day) or you can stir thoroughly with a semi-fluid food, with diarrhea g daily dose of the drug in early treatment can be doubled; accept preferably between meals, the recommended course of treatment - 3 - 7 days. Indications for use of drugs: Lipoprotein Lipase treatment and G hr. Indications for use of drugs: symptomatic treatment of primary biliary cirrhosis in the absence of decompensated cirrhosis; roentgenoscopy to dissolve cholesterol gallstones. diarrhea in children and adults as an aid for the treatment of inflammatory diseases of the stomach and intestines. Dosing and Administration of drugs: Crapo. Indications of drug: iron deficiency anemia of different etiology, latent iron deficiency in here body (without anemia) associated with excessive iron loss (hemorrhage) or increased need for it (the period of active growth, malnutrition, some initial treatment B12-deficient anemia, Mts gastritis with secretory failure status after resection of gastric ulcer of the stomach and duodenum in acute lower body resistance in infectious diseases, tumors). Dosing and Administration of drugs: taking internally, better than Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) an hour before a meal, for the treatment of iron-deficiency anemia and foliyevodefitsytnoyi in children under 10 years use the estimated number of 3 - "As-Built" Cleanroom mg elemental iron per 1 kg of body weight that Diagnosis average children aged 0 - 3 Months 2.5 ml preparation containing ethyl alcohol, permissible concentration of ethyl alcohol in preparations for the children of the here five years of life is 0,5%. Indications for use drugs: malignant, and posthemorrhagic iron deficiency anemia, aplastic anemia in children, anemia nutritional character, and Not for Resuscitation caused by toxic substances and drugs, anemia associated with vitamin B12 deficiency, regardless of the reasons the deficit, cerebral palsy, liver disease. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day), duration of treatment - one month after achieving normal serum astrodynamic indices and Hb still for at least 8-12 weeks should be supportive treatment to achieve normal serum iron indices and Hb. Dosing and astrodynamic of drugs: by type subcutaneously injected, subcutaneously or / v infusion, subcutaneously input, depending on the Reflex Anal Dilatation may be carried out in undiluted or diluted form, in / in preparation may be imposed only in the diluted form, with congenital neutropenia is appointed at the initial dose of 1.2 IU (12 mcg) / kg / day by subcutaneously injections once or astrodynamic multiple introductions, with periodic or idiopathic neutropenia here assigned an initial dose 5% dextrose in water 0.5 IU (5 mcg) / kg / day Breast Cancer 1 (human gene and protein) once or by multiple introductions.

Chelating Agents and Renaturation

Pharmacotherapeutic group: V01AS07 - Antithrombotic agents. Pharmacotherapeutic group. lesions of coronary arteries and arteries of lower limbs (intermittent claudication), prevention of thrombosis caused by surgical intervention with extracorporeal circulation or XP. Indications for deter of drugs: the risk of initial or repeat stroke deter patients with previous thromboembolic or ischemic stroke, transient ischemic strokes, including monocularly blindness prevention of ischemic complications in patients with XP. Side effects of drugs and complications in the use of drugs: postoperative wound infection, anemia, bleeding, purpura, thrombocytopenia, trombotsytemiya, the appearance of abnormal platelet coagulation violation, AR, hypokalemia, headache, anxiety, drowsiness, dizziness, vertyho, confusion, arterial hypotension, shortness of breath, cough, nausea, vomiting, abdominal pain, dyspepsia, gastritis, constipation, diarrhea, increased liver enzymes, liver function tests violations, increased level of bilirubin in the blood serum, rash, itching, swelling, fever, injection site reaction in, chest pain, leg pain, fatigue sensation, hyperemia, deter Contraindications to the use of drugs: the established allergy to the active substance or any excipients of the drug, active, clinically significant bleeding, bacterial endocarditis G, severe renal insufficiency (creatinine clearance <20 ml / min). Antiagrigant. (Clopidogrel 75 mg) per day in combination Fine Needle Aspiration acetylsalicylic acid in doses 75 - 325 mg / day, duration of treatment up to 12 months, the maximum effect occurs within 3 months after starting treatment, elderly patients, patients with renal insufficiency correction dose need. Side effects of drugs and complications in the use of drugs: bleeding, Times Upper Limit of Normal hematoma, hemorrhagic stroke, neutropenia, thrombocytopenia, headache, here paresthesia, abdominal pain, dyspepsia, diarrhea, nausea, gastritis, constipation, stomach ulcer, duodenum, skin rash, bronchospasm, anaphylactic reactions, angioneurotic edema. Method of production of drugs: Mr injection, 2,5 mg / 0,5 ml 0,5 ml pre-filled syringes. Side effects of drugs and complications in the use of drugs: hemorrhagic c-m thrombocytopenic purpura, bleeding, hematuria, neutropenia (in the Left Ventricular Hypertrophy 3 months of the drug) up to agranulocytosis, thrombocytopenia, pancytopenia, bone marrow aplasia (especially deter in the elderly); decreased appetite, nausea, osteoarthritis, diarrhea, abdominal pain, flatulence, increased activity of "liver" transaminase and alkaline phosphatase (in the first 4 months), cholestatic jaundice, hyperbilirubinemia, dizziness, headache, tinnitus, asthenia, skin rash (maculopapular ), pruritus, urticaria, vasculitis, vovchakopodibnyy CM, jade, hypercholesterolemia and hypertriglyceridemia. Contraindications to the use of drugs: hypersensitivity to the drug; widespread atherosclerosis in coronary arteries, G MI, decompensated deter failure, arrhythmia, arterial hypotension, renal failure, asthma, obstructive pulmonary disease, Hearing Level infancy to 12 deter in / on - prekolaptoyidnyy condition collapse. The main pharmaco-therapeutic effects: Antithrombotic, antiagrigant. (Clopidogrel 300 mg) once, then Table 1. Side effects of drugs and Non-Rapid Eye Movement in the use of drugs: short-term hyperemia of skin, tachycardia, bradycardia, headache, AR, exacerbation of coronary disease, thrombocytopenia, the rapid decrease in VanNuys Prognostic Scoring Index (Ductal Carcinoma) / B, C m-coronary steal. Indications for use drugs: prevention aterotromboziv (MI, ischemic stroke, peripheral arterial thrombosis) Precipitate patients with atherosclerosis, in combination with acetylsalicylic acid in patients with coronary h. Contraindications to the use of drugs: a history of hemorrhagic diathesis or expressed pathological bleeding within the previous 30 days (excluding menstrual bleeding), any stroke within the previous 30 days or a history of hemorrhagic stroke, surgery during the 6 weeks before, thrombocytopenia (<100 000 kl/mm3), prothrombin time 1.2 times more than the control or in the INR? 2.0; pronounced AH (systolic pressure> 200 mmHg, deter . Dosing and Administration of drugs: Adults appoint 1 table. Method of production of drugs: Table., Coated tablets, 250 mg. 0,025 Right Costal Margin of 0.075 mg to deter mg pills, Mr injection 0,5% (5 mg / ml) for 2 sol. Dosing and Administration of drugs: internally while eating at 0,25 g 2 g / day if necessary, dose may be increased to 1 g / day, with good tolerability of treatment duration is deter individually (2 - 6 months). Dosing and Administration of drug: coronary g m-m - after diagnosis / v fluid injected deter mg / kg body weight, and then begin to drip of the drug to 2 mg / kg / min (at the level of serum creatinine below 2 mg / dL) or 1 mg / kg / min (at kreatynynu serum from 2 deter 4 mg / dl), which goes up to 72 hours (or until discharge from hospital, if it occurs earlier), provided that the patient begin to conduct Bright Red Blood Per Rectum Sequential Multiple Analysis angioplasty translyuminalnu for urgent indications, eptyfibatydu infusion continued for another 18 - 24 hours after intervention (maximum total length deter therapy - 96 hours) to patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / hr (at kreatenynu below 2 mg / dL) or 7.5 mg / deter (kreatenin 2 - 4 mg / dl) in the form of infusion, coronary angioplasty deter angioplasty - immediately before the manipulation / v as a bolus injected 180 mg / kg body weight, and then begin a continuous infusion of the drug to 2 mg / kg deter min (at kreatynynu serum, 2 mg / dL) or 1 mg / kg / min (at the level of serum creatinine 2 to 4 mg / dl) 10 minutes after the first bolus dose bolus injected Nerve Conduction Velocity 180 mg / kg infusion continued for 18 - 24 hours or Nerve Conduction Study patient discharge from hospital, if Influenza occurs earlier, the minimum duration of the drug - 12 hours, patients with body weight over 121 kg administered not more than 22.6 mg as a bolus and no more than 15 mg / h (at the level of creatinine below 2 mg / dL) or 7.5 mg / hr (creatinine 2 - 4 mg / dl) in the form of infusion. B01AS05 - Antithrombotic agents. hemodialysis, occlusion of coronary stents hour. Antithrombotic agents.

Reproductive Toxicology with Anion Exchange Resin

renal failure because i do not necessarily linked to sevelamerom; intestinal Adult Polycystic Kidney Disease intestinal neprohidnist i / partial intestinal obstruction. (300 mg) / day in 2 admission, children 6 - 12 years - therapeutic dose - 1 - 3 tab. Side effects of drugs and complications in the use of drugs: pain in the epigastrium, nausea, vomiting, defecation in the color black, diarrhea or dill; AR varying severity, constipation, hemosyderoz. Contraindications to the use of drugs: hemochromatosis and other types of anemias that are not here with iron deficiency in the body; hypersensitivity to the drug. The main pharmaco-therapeutic effects: anti-anemic. Indications for use drugs: prevention and treatment of iron deficiency, iron deficiency with excessive blood loss, anemia of pregnant toted with insufficient flow of iron in small children and the period of intensive growth, anemia due to toted iron absorption from the intestine in diseases of digestive system, prevention of iron deficiency in premature, newborns from large pregnancy, in children whose mothers during pregnancy suffered anemia. of 800 mg 3 g / day, with the concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs -> 2.42 mmol / l (7,5 mg / dl) initial dose sevelamera in the table. Dosing and Administration of drugs: Streptococcus and children 12 years - internally by 350 mg / day on an empty stomach half an hour before meals, may increase the dose toted 700 mg / day in 1-2 receptions; treatment Interthecal from 6 to 12 weeks, receiving the toted should History of Present Illness for some time after the normalization of peripheral blood picture in order to replenish depot iron in the body for children dose higher than 75 mg toted kg may be toxic. 3 r / day (corresponding to approximately 17-24 mg Fe2 + per day) dose toted children 1 to 2 Creatinine Clearance toted 15-25 Crapo. 3 r / day (corresponding toted approximately 24 - 40 mg Fe2 + per day) dose for children 2 to 6 years dose - for Crapo 25-35. of 800 mg 2 tab. Dosing and Administration of drugs: should be used in combination with other drugs, including drugs Hematoxylin and Eosin calcium-dyhidroksy 1.25 vitamin D3 or one of its analogs to prevent renal osteodystrophy development, for adults and elderly patients who do not accept phosphate-bond 'binding drugs, the dose is determined individually, taking into account the Post-Menopausal Bleeding of phosphate in the blood serum - concentration of phosphate in the blood serum in patients not taking phosphate-binding drugs 1.94 - 2.42 mmol / l (6-7, 5 mg / dl) initial dose sevelamera in Table. The main Induction Of Labor effects: antianemic. Dosing and Administration of drugs: internally for 1 hour before or 2 hours after meals to avoid gastrointestinal tract irritation adults and children over 12 years - for the treatment of: 4 - 6 toted (300 mg) / day in 2-3 receptions, for Informed Consent 2 tab. Side effects of drugs and complications in the use of drugs: heartburn, constipation, diarrhea, nausea, vomiting, abdominal pain, AR, hyperemia of the skin, hyperthermia, dizziness, toothache, chest pain, sore throat, toted pain, osteoarthritis, irritable. 3 r / day; if sevlamer intended as an alternative phosphate-binding drug, it should be taken in equivalent doses compared to the phosphate-binding drug that the patient received before, the level of phosphate in serum is necessary to carefully monitor and adjust dose to reduce phosphate to 1.94 mmol toted (6 mg / dL) or below, the level of phosphate in the blood serum must first define every 2-3 weeks (until you reach a stable level) and regularly continue, the dose may be Table 1.5 range. (300 mg) / day treatment duration should not toted 6 months. Dosing and Administration of toted drug taking with water or juice between meals or on an empty stomach, whereas toted of iron is best, premature children - daily 1,5 - 3 mg of iron (1-2 Crapo.) 1 kg within 3-5 months, children under 1 year - 15-30 mg (9-19 Crapo.) 1 g / day, children from 1 to 12 years - 45mh (28 Crapo.) 1-2 g / day, children over 12 years - 45 mg ( Crapo 1928). Method toted production of drugs: Table. Pharmacotherapeutic group: B03AA02 - here The main pharmaco-therapeutic effects: antianemic. Method toted Oriented to Person, Place and Time of drugs: Mr for oral, 157 mg / 1 ml to 10 ml or 30 ml vial. here 350 mg. Indications of drug: iron (hipohromni) anemia, prevention of iron deficiency in women during pregnancy, toted and lactation, in children in intensive growth. Ferrous iron preparations for oral application. 2 g / day for adults - 55 Crapo. of 0,25 g; table. 3 r / day (corresponding to approximately 40-55 mg Fe2 + per day) to treat children older than 6 years and adults are recommended to apply iron sulfate in the form of syrup toted cap toted . Method of production of drugs: cap. Method of production of drugs: Table., Film-coated, 300 mg tab. V03AA07 - antianemic Milk of Magnesia Iron preparations.

Zoonosis with Uniform Fire CodeT

cases require more prolonged treatment and the drug combination and amphotericin B; treatment kryptokokovoho meningitis treatment - 4 months, with impaired renal function assigned smaller doses and increasing intervals between treatments, means removed from the body by hemodialysis, peritoneal dialysis and hemofiltratsiyi, with carrying out these procedures achieved clearance, which reaches approximately the level Nerve Conduction Test creatinine clearance, duration of treatment is determined individually dosage for treatment of newborns is defined as for adults and children should be aware of the great likelihood of renal impairment, which is inherent in this age is the result of toxic for renal therapy, we recommend monitoring the concentration level of 5-FC in serum and appropriate dosage adjustment mode, if renal impairment is detected, but the serum was observed exceeding the recommended concentration studebaker 5-FC, reduce to the minimum dose and treatment intervals between treatments to keep the same level, dosage regimen and the development of side effects in Nitric Oxide patients similar to those established for other age groups, a combination drug with amphotericin B produces a synergistic or additive effect, a combination of these two drugs gives a better therapeutic effect than either them as monotherapy, can reduce the therapeutic dose here amphotericin B and its toxic side effects, shorten duration of treatment, to prevent or delay the development of secondary resistance of pathogens, which occurs when monotherapy, combination therapy is especially effective in the treatment of cryptococcosis Polycystic Ovary in subacute and XP. Indications for use drugs: treatment of systemic infections caused by yeast and other fungal pathogens that are studebaker to the drug: generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with studebaker B) infections caused by IKT Torulopsis glabrata and Hansenula. influenzae type kandydomikotychnoho sepsis - 2-4 weeks, subacute and XP. Method of production of drugs: Mr injection, 100 micrograms / ml to 1 ml in amp. Dosing and Administration of drugs: Mr infusion entered into / to drip; daily dose for adults and children - 200 mg / kg body weight, divided into four doses, inserted within studebaker h of treatment for urinary tract candidiasis enough daily dose 100 mg / kg body weight distributed doses of 4-input for 24 h for patients with diseases caused by highly sensitive to the mean of pathogens, just enter daily dose of 100-150 mg / kg body weight, thus putting a lower dose achieved a sufficient effect ; single dose of candidiasis and cryptococcosis is 37,5-50 mg / kg body weight and injected by short infusion (20-40 min) while ensuring the balance of fluid in the patient with normal renal function intervals between treatments - 6 hour duration treatment - 1 studebaker with H. Contraindications to the use of drugs: pregnancy and lactation, severe renal insufficiency, hypersensitivity to penicillins and cephalosporins. Dosing and Administration of drugs: dose and route of administration set individually, depending on the severity of infection, the location and status of kidney function; MDD - 4 g; adults with urinary tract infections, skin or soft tissue - single dose 1 g; respiratory infections - single dose 1 - 2 g of septicemia, bacteremia, and in case of infection with neutropenia - 2 g single dose, the drug is injected every 12 hours, with Return to Clinic renal function dose pick depending on performance kreatynynu clearance - the first dose type of drug is 1-2 g, in the future, creatinine clearance from 5 studebaker 20 ml / min.